Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-24 @ 7:10 PM
NCT ID:
NCT05897203
Eligibility Criteria:
Inclusion Criteria: ALl adults who
* fulfill ARI case definition
* have signs and symptoms of ARI
* test positive for one of the target respiratory viruses (SARS-CoV2, RSV, or Influenza A/B)
* do not have symptoms suggestive of Pulmonary TB i.e cough for more than 2 weeks, drenching night sweats, evening fevers and marked weight loss.
* can provide informed consent or have a surrogate or legally appointed representative to give consent
Exclusion Criteria:
* Severe acute respiratory illness (SARI)-defined as An acute respiratory illness with a history of fever or measured fever of ≥ 38 °C and cough and/or throat with onset within the past 10 days, requiring hospitalization or with SPO2≤92%
* History of hypersensitivity to the investigational product or components therein
* Conditions that may be regarded as contraindications to the investigational medicinal product include known allergic reactions and rashes to any herbal medicines and any untoward reactions to any herbal medications such as bleeding, headaches, high blood pressure, heart failure, seizures, agitation, etc.
* Severe organ impairment (liver, kidney, brain, heart)
* Inability to return for post-discharge follow-up
* Females who are pregnant or intend to become pregnant or are breastfeeding during the trial
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05897203
Study Brief:
Protocol Section:
NCT05897203